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Abstract
Background. Bed rest is prescribed for all patients after cardiovascular implantable elec-
tronic device (CIED) placement but to a varied extent. Different clinical protocols exist.
Aim. To assess the effects of different lengths of bed rest on complications and patient 
comfort after CIED implantation.
Methods. We searched MEDLINE, EMBASE, Cochrane Database of Systematic Re-
views, CINAHL, SCOPUS. We included randomized and quasi-randomized controlled 
trials. Two of the authors independently selected trials, assessed the risk of bias, and 
extracted data.
Results. We included 2 RCTs. There was no evidence that shorter bed rest was more 
harmful than longer bed rest in terms of lead displacement (RR 0.681, 95% CI [0.063, 
7.332]) and hematoma (RR 1.642, 95% CI [0.282, 9.560]). None of the studies reported 
the assessment of bleeding, back pain, or urinary discomfort.
Conclusions. Shorter periods of bed rest appear to be as safe as longer ones. However, 
to confirm these results, further larger trials are needed.
INTRODUCTION
Cardiovascular implantable electronic device (CIED) 
is a term that encompasses pacemakers (PMs) for 
bradyarrhythmia treatment, implantable cardioverter 
defibrillators (ICDs) for life-threatening ventricular 
tachyarrhythmia management, and cardiac resynchro-
nization therapy (CRT) devices for systolic dysfunction 
with conduction delays [1]. CIEDs were introduced 
into routine clinical practice in the 1960s and, since 
then, their use has increased worldwide [2]. In 2009, 
Mond and Proclemer performed the latest worldwide 
cardiac pacing and implantable cardioverter-defibrilla-
tor (ICD) survey [3], and all countries showed increas-
es in implant numbers compared to data from a similar 
survey carried out in 2005 by Mond et al. [4]. Perma-
nent cardiac pacing is one of the most important medi-
cal innovations of the 20th century [5], and it remains 
the only effective treatment for chronic, symptomatic 
bradycardia [6].
A CIED relies on two essential components: a pulse 
generator, that includes software and an integrated bat-
tery, and leads implanted in the heart chambers and 
connected to the generator [7, 8].
CIED implantation [8, 9] is typically performed un-
der local anesthesia in a cardiac catheterization labora-
tory. An incision is made in the upper chest, slightly 
inferior and medial to the deltopectoral groove. A 
pocket is created for placement of the pulse generator 
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by separating the subcutaneous tissue from the pecto-
ral muscle at the fascial plane. Transvenous access is 
achieved via the subclavian or cephalic veins, located 
just below the collarbone. The leads are advanced un-
der fluoroscopy to guide them into the correct posi-
tion through the superior vena cava into the heart and 
then are placed in the appropriate chambers. Once the 
leads are positioned in the heart, the CIED is tested to 
verify proper location and that it is working correctly. 
The skin incision is closed with sutures and a sterile 
dressing is applied.
The most common short-term CIED implantation-
related complications are [10, 11]: pocket hematoma, 
pocket infection, lead displacement, venous thrombo-
sis, pneumothorax, hemothorax, and cardiac perfora-
tion.
Kirkfeldt et al. [12] indicated that 9.5% of patients 
who underwent a CIED procedure experienced at least 
one complication. In particular, one study conducted in 
the USA highlighted that dislodgement, pocket hema-
toma, and pneumothorax after ICD implantation oc-
curred in 1%, 0.9% and 0.4% of patients, respectively 
[13]. A different study [14] indicated that 4.4% of pa-
tients developed some perioperative complications after 
permanent PM insertion, and the most common ones 
were lead dislodgement (1.7%), pneumothorax (1.0%), 
and pocket hematoma (0.2%).
In order to reduce complications, nursing care is im-
portant. However, there are no international guidelines 
addressing postoperative care [15], and no final conclu-
sion has yet been reached concerning patient mobiliza-
tion and bed rest prescription to prevent complications 
after CIED implantation [16, 17]. Many different pro-
tocols exist and, conventionally, patients are prescribed 
at least 24 h of bed rest, as this is thought to prevent 
short-term implantation-related complications, with 
particular reference to lead displacement [18].
Bed rest is associated with impairment of the mus-
culoskeletal, cardiovascular, respiratory, integumen-
tary, gastrointestinal, and renal systems, as well as cog-
nition, and it is a potentially harmful treatment [19, 
20]. Lack of mobility can be devastating, especially for 
older patients, because functional decline can happen 
quickly [21]. Mandatory supination is often uncom-
fortable and can cause lumbodorsalgia and urinary 
retention [22]. Conversely, early mobilization reduces 
patient discomfort and postural pain, promotes dig-
nity and independence, and prevents the side effects 
of bed rest.
The main objective of this systematic review was 
to assess the effects of different lengths of bed rest 
on complications and patient discomfort after CIED 
placement.
METHODS
Types of study
We conducted this systematic review in accordance 
with the Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) [23] statement.
We included randomized and quasi-randomized con-
trolled trials comparing different lengths of bed rest. 
We defined the search query using the following PICO 
framework [24] (Table 1).
Participants
This review included studies which enrolled patients 
undergoing CIED placement. There were no restric-
tions with respect to patient characteristics or health-
care setting. 
Interventions and comparisons
Duration of bed rest was the intervention of interest 
for this review. We compared early mobilization with 
late mobilization. 
Outcomes
According to Saldanha et al., the outcomes were de-
fined using 5 items: domain, specific measurements, 
specific metric, method, time point [25]. 
Primary outcome
Domain: lead displacement 
Specific measurement: number of patients with lead 
displacement. The displacement was defined as the in-
ability to pace the myocardium even at a high voltage 
output, sensing defects not corrigible by reprogram-
ming the device, or radiographic evidence of dislodge-
ment.
Specific metric: value at time point. 
Method of aggregation: percentage. 
Time point: 24 h after CIED placement or discharge 
time. 
Secondary outcomes
Domain: bleeding. 
Specific measurement: number of patients presenting 
visible areas of bleeding, oozing, or hemorrhage at the 
CIED implantation site. 
Specific metric: value at time point. 
Method of aggregation: percentage. 
Time point: 24 h after CIED placement or discharge 
time.
Domain: hematomas. 
Specific measurement: number of patients presenting 
visible ecchymosis or hematoma at the CIED implanta-
tion site. 
Specific metric: value at time point. 
Table 1
Description of PICO framework [24] used to define the search query.
PICO framework Description
Population Patients undergoing CIED placement 
Intervention/Comparison Short bed rest (such as 3 h) vs long bed rest 
Outcomes Lead displacement; bleeding; hematomas; back pain; urinary discomfort
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Method of aggregation: percentage. 
Time point: 24 h after CIED placement or discharge 
time.
Domain: back pain. 
Specific measurement: number of patients presenting 
with back pain after CIED placement.
Specific metric: value at time point. 
Method of aggregation: percentage. 
Time point: 24 h after CIED placement or discharge 
time.
Domain: urinary discomfort. 
Specific measurement: number of patients presenting 
with urinary discomfort after CIED placement. 
Specific metric: value at time point. 
Method of aggregation: percentage. 
Time point: 24 h after CIED placement or discharge 
time.
Electronic research
We conducted a comprehensive search including: 
MEDLINE, EMBASE, Cochrane Database of System-
atic Reviews, CINAHL, and SCOPUS. The search strat-
egies are shown in Appendix 1 available online as Supple-
mentary Materials. In order to identify other published 
and unpublished works (grey literature) we consulted 
google scholar. In addition, we manually inspected previ-
ous reviews to obtain relevant studies from their list of 
references. We did not apply language restrictions.
Study selection
Two of the authors (SM and SG) independently 
screened titles and abstracts in order to identify rel-
evant publications. Disagreements were resolved by 
discussion with a third author (GB) who made the final 
decision. Full texts were retrieved and evaluated by the 
same two authors.
Agreement among the screeners was assessed using 
Cohen Kappa: if K < 0.20 the correlation was poor; fair 
if between 0.21 and 0.40; moderate if between 0.41 and 
0.60; good if between 0.61 and 0.80 and very good if ≥ 
0.81 [26]. 
Data extraction
If eligible studies were found, two authors (AC and 
SG) would independently extract and enter the data 
into tables using Excel. If data from the trial reports was 
insufficient, the original authors would be contacted for 
further information. The following data was extracted:
• article (title, authors, years of publication, journal);
• study characteristics (setting and location of study, 
number of patients, mean patient age, duration of 
bed rest, type of study, type of device, type of com-
pression);
• results (number of patients per study group, number 
of patients presenting complications);
• other relevant information.
Assessment of risk of bias in included studies
Two review authors (EB and RC) assessed the quality 
of included studies using the Cochrane Effective Prac-
tice and Organisation of Care (EPOC) Risk of Bias tool 
[27]. The following domains were evaluated:
• selection bias;
• performance bias;
• detection bias;
• attrition bias;
• reporting bias.
Any differences among the review authors were re-
solved by discussion or by consensus after negotiation 
with a third author (ADM).
Statistical analysis
The selected studies are homogeneous enough with 
respect to design and outcomes, so we have conducted 
a meta-analysis. All outcomes are dichotomous and 
were analyzed as OR / RR with a corresponding 95% 
CI. The meta-analysis gave estimates with null or not 
statistically significant heterogeneity. Statistical hetero-
geneity was tested with I-squared and corresponding 
p-values. For the meta-analysis, the Manthel-Haenszel 
model of fixed effects was used. 
RESULTS
Literature search results
Comprehensive literature searching yielded 751 refer-
ences (conducted in October 2016). After title/abstract 
screening, 739 records were excluded (Cohen’s K 0.515). 
Of the remaining 12 studies, 10 were excluded (Cohen’s 
K 1) because they were observational studies or because 
the intervention was not short versus long bed rest. Thus, 
2 studies were included [28, 29] (Figure 1).
Selected studies
We have included two RCTs. Both studies were con-
ducted in Italy and included patients who underwent 
PM implantation. No studies including patients who 
underwent ICD or CRT device placement were found 
(Table 2).
Participants
There were a total of 166 participants with a mean 
attrition rate of 2.6% (SD 0.04). The selected studies 
observed mixed samples for gender: 50% of the total 
participants were female. The mean age of the partici-
pants was 75.7 years (95% CI 61.3-90.0; SD 5.77), with 
a total range from 18 to 94 years old.
Miracapillo et al. [29] also conducted an analysis by 
subgroups, dividing patients according to the implanted 
leads and pacemaker (single-lead and dual-lead) which 
were equally distributed throughout the intervention 
and control groups. In the second study, a dual-chamber 
pacemaker was implanted in the majority of patients.
Intervention
In the experimental group, there were a total of 73 
participants (mean 24.3, SD 7.37, min 16, max 30), 40 
male and 33 female with a mean age of 75.5 (SD 6.062, 
min 68.5, max 79), who were mobilized at 180 min = 3 
h after surgery.
Control
In the control group, there were a total of 93 partici-
pants (mean 31, SD 13.2, min 16, max 41), 43 male and 
50 female with a mean age of 75.333 (SD 4.618, min 70, 
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max 78). In the control group, the postoperative mobi-
lization of patients happened after a mean of 1680 min 
= 28 h (SD 415, min 1440 = 24 h, max 2160 = 36 h).
Outcomes 
The two included studies evaluated lead displace-
ment, pocket hematoma, and other postoperative com-
plications until discharge. Miracapillo et al. [29] also 
scheduled a 2-month follow up. No studies evaluating 
bleeding, back pain, or urinary discomfort were found.
Methodological quality of the selected studies
The quality of the included studies was assessed us-
ing the Cochrane Effective Practice and Organisation 
of Care (EPOC) Risk of Bias tool [27].
Risk of bias summary (Figure 2) shows review au-
Figure 1 
PRISMA [23] flow diagram depicting the flow of information through the different phases of the systematic review. It maps out the 
number of records identified, included and excluded, and the reasons for exclusions.
Table 2
Characteristics of the two studies included in the review
First author (year) and 
country
Miracapillo (2006) 
Italy [29]
Simonelli (2012) 
Italy [28]
Study design and time 
frame
RCT 
March 2003-February 2004
RCT 
September 2010-December 2010
Participants 134 patients undergoing PM implantation (71 single-
chamber and 63 dual-chamber)
32 patients undergoing PM implantation (31 dual-
chamber and 1 single-chamber)
Intervention 57 patients were mobilized 3 hours after surgery 16 patients were mobilized 3 hours after surgery
Control 77 patients were mobilized 24 hours after surgery 16 patients were mobilized 36 hours after surgery
Outcomes Lead displacement, high pacing thresholds at the 
electronic follow-up and clinical complications of the 
pocket such as hematoma formation, infection, or PM 
vein thrombosis
Lead displacement, clinical complications of the 
pocket (such as hematoma formation, infection, or 
PM vein thrombosis), nausea/vomiting, need for 
analgesics and level of independenc.
Follow-up Clinical and electronical follow-up were performed 
both 24 hours after implantation and two months 
later
Level of indepence was assessed at 6, 12, and 36 
hours after implantation. Clinical follow-up was 
performed at hospital discharge
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thors’ judgements about each risk of bias item for each 
included study. The two studies explicitly used proper 
randomization methods. Blinding of participants is 
generally difficult to obtain with these types of inter-
vention. Trials are open label, but this review is based 
on objective outcome parameters. The included studies 
also suffered from insufficient information about blind-
ing of outcome assessors. Study protocol was available 
for Simonelli et al. [28].
Meta-analysis 
Those studies were essentially comparable for length 
of bed rest and patient characteristics. Therefore, we 
attempted a formal meta-analysis (Table 3).
Primary outcome
Lead displacement was reported in the Miracapillo 
study [29] while in the Simonelli study [28] no lead dis-
placement was observed in both the experimental and 
control groups. No differences were found for length of 
bed rest (RR 0.681, 95%, CI [0.063, 7.332]). 
Secondary outcomes
Hematoma was reported in both studies. There 
was no evidence that duration of bed rest was associ-
ated with this complication (RR 1.642, 95% CI [0.282, 
9.560]).
DISCUSSION
The aim of this systematic review was to assess the ef-
fects of length of bed rest on complications and patient 
discomfort after CIED placement.
We included two RCTs comprising a total of 166 
participants who underwent PM implantation, a low 
sample size if we consider that the latest published 
worldwide survey [3] described 737 840 new PM im-
plantation procedures carried out during the 2009 cal-
endar year. No studies including patients who under-
went ICD nor CRT device were found.
The included studies are homogeneous enough with 
respect to design and outcomes, and they are essen-
tially comparable for length of bed rest and patient 
characteristics. Low sample size notwithstanding, we 
decided to carry out a formal meta-analysis in order to 
elaborate on this topic of great clinical and economic 
interest and encourage researchers to develop new tri-
als as well.
This systematic review stated that there is no evi-
dence of lead displacement and pocket hematoma due 
to early mobilization of patients who underwent PM 
implantation. In both studies an elastic bandage was 
put on the homolateral shoulder after the procedure. 
It can be useful against hemorrhagic complications of 
the pocket and opening of the wound margins. Results 
of this study support a decrease in bed rest times with-
out an increase in complication rates. According to the 
existing evidence, 3 h of bed rest would seem to be as 
safe as longer periods of bed rest. Shorter lengths of bed 
rest may suggest an early discharge policy. The litera-
ture does not state the time of discharge. Miracapillo 
et al. [29] suggests scheduling earlier follow-up to easily 
detect lead dislodgement, which can be very dangerous 
in pacemaker-dependent patients. In this study, two 
events occurred in the period between discharge and 
the 2-month follow-up.
The trials included in this review had satisfactory 
methodological quality according to the Cochrane Ef-
fective Practice and Organisation of Care (EPOC) Risk 
of Bias tool [27]; however, both studies had limitations 
related to blinding criteria, and the sample sizes were 
small, particularly for the Simonelli study [28].
To the best of our knowledge, there is no any other 
published meta-analysis addressing the same issue, so 
we considered papers dealing with similar questions: a 
Cochrane review comparing the effects of shorter ver-
sus longer periods of bed rest in patients with uncom-
plicated acute myocardial infarction [30] stated that 
short bed rest appears to be as safe as longer periods 
of bed rest in terms of mortality or reinfarction, while a 
recent systematic review comparing the effects of early 
mobilization with no treatment in patients after cardiac 
surgery [31] stated that early mobilization seems to be 
important to prevent postoperative complications, im-
prove functional capacity, and reduce length of hospital 
stay. Finding comparable results in papers addressing 
similar issues suggest that an evidence-based approach 
to reducing bed rest in the cardiology patient popula-
Figure 2 
Risk of bias summary. The quality of included studies was as-
sessed using the Cochrane EPOC Risk of Bias tool [27].
Table 3
Meta-analysis results. Comparison: early mobilization (3 hours) versus longer bed rest
Outcome RR 95% CI p I-squared
Lead displacement 0.681 0.063, 7.332 0.751 -
Hematoma 1.642 0.282, 9.560 0.581 0.0%
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tion is underway. There is growing interest in the use 
of early mobilization in the hospital setting, because a 
shorter length of bed rest is an inexpensive and easily 
performed strategy that can affect quality of care and 
patient comfort. A systematic review and network me-
ta-analysis assessing the effects of different lengths of 
bed rest after transfemoral cardiac catheterization on 
bleeding and hematoma, other vascular complications, 
patient symptoms and discomfort is being carried out 
[32], while others have been concluded [33, 34].
A limitation of this review could be that during re-
cords screening we excluded 6 references because the 
full text was not available; nevertheless, after careful 
reading of the 6 abstracts, we determined that those 
papers would not have significantly affected this study.
Further larger trials would be useful to validate the 
safety and effectiveness of early mobilization for pa-
tients undergoing CIED implantation and to establish 
the optimal duration of bed rest. In future studies, pain 
scores need to be captured, as safety and comfort are 
important quality measures.
RCTs to evaluate the effect of immediate mobiliza-
tion compared with early mobilization in patients un-
dergoing CIED implantation could be a possible way 
forward.
CONCLUSION
Current practice is moving to markedly shorter du-
rations of bed rest during hospital stays. It is possible 
to assume safety and effectiveness of early mobilization 
for patients who underwent PM implantation. The doc-
tors and nurses could consider early mobilization for pa-
tients undergoing PM implantation. However, in order 
to confirm our results larger studies must be carried out. 
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